Pacylex Pharmaceuticals Announces First Patient Dosed in a Phase 2a Study of PCLX-001 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease
FDA Confirms Eligibility of XORLO™ for Accelerated Approval
RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across Canada
Is Canada ready? Routine use of genome based testing in Canada’s Major Regions. A State of Readiness Progress Report
Syantra Receives CE Mark Approval for their Breast Cancer Test Built on the Syantra DX™ Liquid Biopsy Platform
GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation
Canada needs to invest now to address antimicrobial resistance
Alberta becomes the first province to list Trodelvy for triple-negative breast cancer
